Publications & Clinical Trials

Vaccine Research:

NeXXstep Study

KIDZ Pediatric Pulmonary Center

• Title: PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age
  • DOI: https://doi.org/10.1016/j.jpeds.2018.09.012
• Title: Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)
  • DOI: https://doi.org/10.1038/s41372-019-0347-4
• Title: Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial
  • DOI: https://doi.org/10.1016/j.jpeds.2019.05.049
• Title: A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
  • DOI: DOI: 10.1056/NEJMoa1907423
• Title: Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN)
  • DOI: https://doi.org/10.1007/s00467-020-04563-x
• Title: Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial
  • DOI: https://doi.org/10.1001/jamapediatrics.2020.2271
• Title: Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial
  • DOI: https://doi.org/10.1016/j.jpeds.2020.09.047
• Title: Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial
  • DOI: https://doi.org/10.1542/peds.2019-3967
• Title: High-Dose Erythropoietin in Extremely Low Gestational Age Neonates Does Not Alter Risk of Retinopathy of Prematurity
  • DOI: https://doi.org/10.1159/000511262

2021:

• 17. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age.
  • Mavunda K, Jiang X, Ambrose CS.
  • J Neonatal Perinatal Med. 2021;14(1):43-51. doi: 10.3233/NPM-200412. PMID: 32474477

2020:

• 16. Traveller exposures to animals: a GeoSentinel analysis
  • Muehlenbein MP, Angelo KM, Schlagenhauf P, Chen L, Grobusch MP, Gautret P, Duvignaud A, Chappuis F, Kain KC, Bottieau E, Epelboin L, Shaw M, Hynes N, Hamer DH; GeoSentinel Surveillance Network.
  • J Travel Med. 2020 Nov 9;27(7):taaa010. doi: 10.1093/jtm/taaa010.
  • PMID: 31993666

• 15. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
  • Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F, Villafana T, DeVincenzo JP; Nirsevimab Study Group.
  • N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556.
  • PMID: 32726528 Clinical Trial.

2019:

• 14. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.
  • Boggild AK, Caumes E, Grobusch MP, Schwartz E, Hynes NA, Libman M, Connor BA, Chakrabarti S, Parola P, Keystone JS, Nash T, Showler AJ, Schunk M, Asgeirsson H, Hamer DH, Kain KC; GeoSentinel Surveillance Network.
  • J Travel Med. 2019 Dec 23;26(8):taz055. doi: 10.1093/jtm/taz055.
  • PMID: 31553455

• 13. The rise in travel-associated measles infections-GeoSentinel, 2015-2019
  • Angelo KM, Libman M, Gautret P, Barnett E, Grobusch MP, Hagmann SHF, Gobbi F, Schwartz E, van Genderen PJJ, Asgeirsson H, Hamer DH; GeoSentinel Surveillance Network.
  • J Travel Med. 2019 Sep 2;26(6):taz046. doi: 10.1093/jtm/taz046.
  • PMID: 31218359

• 12. International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study
  • Gautret P, Angelo KM, Asgeirsson H, Duvignaud A, van Genderen PJJ, Bottieau E, Chen LH, Parker S, Connor BA, Barnett ED, Libman M, Hamer DH; GeoSentinel Network.
  • Travel Med Infect Dis. 2019 Nov 9;32:101504. doi:
  • 10.1016/j.tmaid.2019.101504. Online ahead of print.
  • PMID: 31707112

2016:

• 11. Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function
  • Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW; Scientific Advisory Group; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis.
  • J Pediatr. 2016 Feb;169:116-21.e2. doi: 10.1016/j.jpeds.2015.08.042. Epub 2015 Sep 19.
  • PMID: 26388208

2013:

• 10. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function
  • Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators; coordinators of the Epidemiologic Study of Cystic Fibrosis.
  • J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013. Epub 2013 Jun 27.
  • PMID: 23810128

• 9. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis
  • Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators.
  • Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.
  • PMID: 23818295 Clinical Trial.

2011:

• 8. Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis
  • Schechter MS, McColley SA, Regelmann W, Millar SJ, Pasta DJ, Wagener JS, Konstan MW, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
  • J Pediatr. 2011 Nov;159(5):819-824.e1. doi: 10.1016/j.jpeds.2011.05.005. Epub 2011 Jun 25.
  • PMID: 21705017

2009:

• 7. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.
  • Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis; North American Scientific Advisory Group for ESCF.
  • J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059. Epub 2009 Jul 16.
  • PMID: 19608199

• 6. A pilot asthma incidence surveillance system and case definition: lessons learned.
  • Trepka MJ, Martin P, Mavunda K, Rodriguez D, Zhang G, Brown C.
  • Public Health Rep. 2009 Mar-Apr;124(2):267-79.
  • doi: 10.1177/003335490912400215.
  • PMID: 19320369

2008:

• 5. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.
  • Light M, Bauman J, Mavunda K, Malinoski F, Eggleston M.
  • Pediatr Infect Dis J. 2008 Jun;27(6):512-8. doi: 10.1097/INF.0b013e318168daf1.
  • PMID: 18449062

1999:

• 4. Children with cystic fibrosis benefit from massage therapy.
  • Hernandez-Reif M, Field T, Krasnegor J, Martinez E, Schwartzman M, Mavunda K.
  • J Pediatr Psychol. 1999 Apr;24(2):175-81. doi: 10.1093/jpepsy/24.2.175.
  • PMID: 10361400 Clinical Trial.

1998:

• 3. Children with asthma have improved pulmonary functions after massage therapy
  • Field T, Henteleff T, Hernandez-Reif M, Martinez E, Mavunda K, Kuhn C, Schanberg S.
  • J Pediatr. 1998 May;132(5):854-8. doi: 10.1016/s0022-3476(98)70317-8.
  • PMID: 9602199 Clinical Trial.

1991:

• 2. Role of flexible bronchoscopy and bronchoalveolar lavage in the diagnosis of pediatric acquired immunodeficiency syndrome-related pulmonary disease
  • Birriel JA Jr, Adams JA, Saldana MA, Mavunda K, Goldfinger S, Vernon D, Holzman B, McKey RM Jr.
  • Pediatrics. 1991 Jun;87(6):897-9.
  • PMID: 2034496

1989:

• 1. Effects of inhaled metaproteronol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia
  • Mavunda K.
  • Pediatr Pulmonol. 1989;7(4):284. doi: 10.1002/ppul.1950070415.
  • PMID: 2616251 No abstract available